BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Simmonds P. Variability of hepatitis C virus. Hepatology. 1995;21:570-583. [PMID: 7531173 DOI: 10.1002/hep.1840210243] [Cited by in Crossref: 339] [Cited by in F6Publishing: 244] [Article Influence: 12.6] [Reference Citation Analysis]
Number Citing Articles
1 Al-Ahdal MN, Rezeig MA, Kessie G. Genotyping of hepatitis C virus isolates from Saudi patients by analysis of sequences from PCR-amplified core region of the virus genome. Ann Saudi Med 1997;17:601-4. [PMID: 17338004 DOI: 10.5144/0256-4947.1997.601] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
2 Mcallister J, Casino C, Davidson F, Power J, Lawlor E, Yap PL, Simmonds P, Smith DB. Long-Term Evolution of the Hypervariable Region of Hepatitis C Virus in a Common-Source-Infected Cohort. J Virol 1998;72:4893-905. [DOI: 10.1128/jvi.72.6.4893-4905.1998] [Cited by in Crossref: 87] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
3 Dusheiko G, Main J, Thomas H, Reichard O, Lee C, Dhillon A, Rassam S, Fryden A, Reesink H, Bassendine M, Norkrans G, Cuypers T, Lelie N, Telfer P, Watson J, Weegink C, Sillikens P, Weiland O. Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study. J Hepatol. 1996;25:591-598. [PMID: 8938532 DOI: 10.1016/s0168-8278(96)80225-x] [Cited by in Crossref: 244] [Cited by in F6Publishing: 59] [Article Influence: 9.8] [Reference Citation Analysis]
4 Simin M, Brok J, Stimac D, Gluud C, Gluud LL, Simin M. Pegylated interferon plus ribavirin versus non-pegylated interferon plus ribavirin for chronic hepatitis C. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd005441] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
5 Othman SB, Trabelsi A, Monnet A, Bouzgarrou N, Grattard F, Beyou A, Bourlet T, Pozzetto B. Evaluation of a prototype HCV NS5b assay for typing strains of hepatitis C virus isolated from Tunisian haemodialysis patients. J Virol Methods 2004;119:177-81. [PMID: 15158600 DOI: 10.1016/j.jviromet.2004.03.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
6 Zekri AR, El-Din HM, Bahnassy AA, El-Shehabi AM, El-Leethy H, Omar A, Khaled HM. TRUGENE sequencing versus INNO-LiPA for sub-genotyping of HCV genotype-4. J Med Virol 2005;75:412-20. [PMID: 15648068 DOI: 10.1002/jmv.20293] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
7 Gish RG, Qian K, Brooks L, Leung J, Xu Y, Pike I, Lau JY. Characterization of anti-hepatitis C virus-positive sera not genotyped by restriction fragment length polymorphism or serology. J Gastroenterol Hepatol 1999;14:339-44. [PMID: 10207783 DOI: 10.1046/j.1440-1746.1999.01856.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
8 Glicklich D, Kapoian T. Should the Hepatitis C Positive End Stage Renal Disease Patient Be Transplanted? Seminars in Dialysis 1996;9:5-8. [DOI: 10.1111/j.1525-139x.1996.tb00889.x] [Cited by in Crossref: 11] [Article Influence: 0.7] [Reference Citation Analysis]
9 Kanduc D, Tessitore L, Lucchese G, Kusalik A, Farber E, Marincola FM. Sequence uniqueness and sequence variability as modulating factors of human anti-HCV humoral immune response. Cancer Immunol Immunother 2008;57:1215-23. [PMID: 18256830 DOI: 10.1007/s00262-008-0456-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
10 Ikeda H, Takasu M, Inoue K, Okamoto H, Miyakawa Y, Mayumi M. Infection with an unenveloped DNA virus (TTV) in patients with acute or chronic liver disease of unknown etiology and in those positive for hepatitis C virus RNA. J Hepatol. 1999;30:205-212. [PMID: 10068097 DOI: 10.1016/s0168-8278(99)80063-4] [Cited by in Crossref: 66] [Cited by in F6Publishing: 10] [Article Influence: 2.9] [Reference Citation Analysis]
11 Hellen CU, Pestova TV. Translation of hepatitis C virus RNA. J Viral Hepat. 1999;6:79-87. [PMID: 10607219 DOI: 10.1046/j.1365-2893.1999.00150.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 2.7] [Reference Citation Analysis]
12 Sakai A, Kaneko S, Matsushita E, Kobayashi K. Floating density of hepatitis C virus particles and response to interferon treatment. J Med Virol 1998;55:12-7. [DOI: 10.1002/(sici)1096-9071(199805)55:1<12::aid-jmv3>3.0.co;2-r] [Cited by in Crossref: 9] [Article Influence: 0.4] [Reference Citation Analysis]
13 Viazov S, Kuzin S, Paladi N, Tchernovetsky M, Isaeva E, Mazhul L, Vasychova F, Widell A, Roggendorf M. Hepatitis C virus genotypes in different regions of the former Soviet Union (Russia, Belarus, Moldova, and Uzbekistan). J Med Virol 1997;53:36-40. [DOI: 10.1002/(sici)1096-9071(199709)53:1<36::aid-jmv7>3.0.co;2-r] [Cited by in Crossref: 47] [Article Influence: 1.9] [Reference Citation Analysis]
14 Farkas DH. Bioelectric Detection of DNA and the Automation of Molecular Diagnostics. JALA: Journal of the Association for Laboratory Automation 1999;4:20-4. [DOI: 10.1016/s1535-5535-04-00029-2] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
15 Al-Khurri LE, Al-Khafaji KR, Al-Salihi SA, Alwaysi SA, Al-Akayshi RJ. Serum HCV-RNA levels in patients with chronic hepatitis C: Correlation with histological features. Arab J Gastroenterol 2009;10:10-3. [PMID: 24842130 DOI: 10.1016/j.ajg.2009.03.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
16 Osella AR, Misciagna G, Guerra V, Elba S, Buongiorno G, Cavallini A, Di Leo A, Sonzogni L, Mondelli MU, Silini EM. Hepatitis C virus genotypes and risk of cirrhosis in southern Italy. Clin Infect Dis. 2001;33:70-75. [PMID: 11389497 DOI: 10.1086/320887] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
17 Vizmanos JL, González-Navarro CJ, Novo FJ, Civeira MP, Prieto J, Gullón A, García-Delgado M. Degree and distribution of variability in the 5' untranslated, E1, E2/NS1 and NS5 regions of the hepatitis C virus (HCV). J Viral Hepat 1998;5:227-40. [PMID: 9751009 DOI: 10.1046/j.1365-2893.1998.00110.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
18 Gargiulo F, De Francesco MA, Pinsi G, Pollara C, Terlenghi L, Perandin F, Manca N. Determination of HCV genotype by direct sequence analysis of quantitative PCR products. J Med Virol 2003;69:202-6. [DOI: 10.1002/jmv.10284] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
19 Chang J, Ruedinger B, Cong M, Lambert S, Lopareva E, Purdy M, Holloway B, Jue D, Ofenloch B, Fields H, Khudyakov Y. Artificial NS4 mosaic antigen of hepatitis C virus. J Med Virol 1999;59:437-50. [DOI: 10.1002/(sici)1096-9071(199912)59:4<437::aid-jmv4>3.0.co;2-5] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
20 Chaudhuri S, Das S, Chowdhury A, Santra A, Bhattacharya SK, Naik TN. Molecular epidemiology of HCV infection among acute and chronic liver disease patients in Kolkata, India. J Clin Virol. 2005;32:38-46. [PMID: 15572005 DOI: 10.1016/j.jcv.2004.07.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 1.2] [Reference Citation Analysis]
21 Kato N, Nakamura T, Dansako H, Namba K, Abe K, Nozaki A, Naka K, Ikeda M, Shimotohno K. Genetic variation and dynamics of hepatitis C virus replicons in long-term cell culture. Journal of General Virology 2005;86:645-56. [DOI: 10.1099/vir.0.80479-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
22 Schleicher SB, Flehmig BF. Genotyping of GB virus C by restriction pattern analysis of the 5? untranslated region. J Med Virol 2003;71:226-32. [DOI: 10.1002/jmv.10474] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
23 Perumpail RB, Hahambis TA, Aggarwal A, Younossi ZM, Ahmed A. Treatment strategies for chronic hepatitis C prior to and following liver transplantation. World J Hepatol 2016; 8(1): 69-73 [PMID: 26783422 DOI: 10.4254/wjh.v8.i1.69] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
24 Aziz H, Raza A, Irfan J. Optimum predictors of therapeutic outcome in HCV patients in Pakistan. J Med Virol 2016;88:100-8. [PMID: 26103918 DOI: 10.1002/jmv.24305] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
25 Reid AE, Koziel MJ, Aiza I, Jeffers L, Reddy R, Schiff E, Lau JY, Dienstag JL, Liang TJ. Hepatitis C virus genotypes and viremia and hepatocellular carcinoma in the United States. Am J Gastroenterol 1999;94:1619-26. [PMID: 10364034 DOI: 10.1111/j.1572-0241.1999.01153.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 1.3] [Reference Citation Analysis]
26 Abraham P, Hallett R, Radhakrishnan S, Raghuraman S, Sridharan G, Teo CG. Hepatitis G virus genotypes in a tertiary care centre in southern India. Journal of Clinical Virology 2002;25:187-92. [DOI: 10.1016/s1386-6532(02)00008-2] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
27 Dansako H, Naganuma A, Nakamura T, Ikeda F, Nozaki A, Kato N. Differential activation of interferon-inducible genes by hepatitis C virus core protein mediated by the interferon stimulated response element. Virus Res. 2003;97:17-30. [PMID: 14550584 DOI: 10.1016/S0168-1702(03)00218-1] [Cited by in Crossref: 46] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
28 Vatteroni M, Maggi F, Morrica A, Fornai C, Giorgi M, Pistello M, Bendinelli M. Comparative evaluation of five rapid methods for identifying subtype 1b and 2c hepatitis C virus isolates. Journal of Virological Methods 1997;66:187-94. [DOI: 10.1016/s0166-0934(97)00054-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
29 Hagan H. Hepatitis C Virus Transmission Dynamics in Injection Drug Users. Substance Use & Misuse 2009;33:1197-212. [DOI: 10.3109/10826089809062214] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 4.5] [Reference Citation Analysis]
30 Malet I, Wychowski C, Huraux J, Agut H, Cahour A. Yellow Fever 5′ Noncoding Region as a Potential Element to Improve Hepatitis C Virus Production through Modification of Translational Control. Biochemical and Biophysical Research Communications 1998;253:257-64. [DOI: 10.1006/bbrc.1998.9740] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
31 Tsubota A, Kumada H, Chayama K, Arase Y, Saitoh S, Koida I, Suzuki Y, Kobayashi M, Murashima N, Ikeda K. Time course of histological changes in patients with a sustained biochemical and virological response to interferon-alpha therapy for chronic hepatitis C virus infection. J Hepatol 1997;27:49-55. [PMID: 9252073 DOI: 10.1016/s0168-8278(97)80279-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
32 Nicot F, Legrand-abravanel F, Sandres-saune K, Boulestin A, Dubois M, Alric L, Vinel J, Pasquier C, Izopet J. Heterogeneity of hepatitis C virus genotype 4 strains circulating in south-western France. Journal of General Virology 2005;86:107-14. [DOI: 10.1099/vir.0.80409-0] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 3.6] [Reference Citation Analysis]
33 Halfon P, Ouzan D, Cattan L, Cacoub P. Les outils du diagnostic de l’infection par le virus de l’hépatite C. La Presse Médicale 2004;33:538-41. [DOI: 10.1016/s0755-4982(04)98660-5] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
34 De Mitri MS, Mele L, Chen CH, Piccinini A, Chianese R, D'Errico A, Alberti A, Pisi E. Comparison of serum and liver hepatitis C virus quasispecies in HCV-related hepatocellular carcinoma. J Hepatol 1998;29:887-92. [PMID: 9875634 DOI: 10.1016/s0168-8278(98)80115-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
35 Mast EE, Alter MJ. Hepatitis C. Seminars in Pediatric Infectious Diseases 1997;8:17-22. [DOI: 10.1016/s1045-1870(97)80005-2] [Cited by in Crossref: 12] [Article Influence: 0.5] [Reference Citation Analysis]
36 Ndjomou J, Pybus OG, Matz B. Phylogenetic analysis of hepatitis C virus isolates indicates a unique pattern of endemic infection in Cameroon. J Gen Virol. 2003;84:2333-2341. [PMID: 12917453 DOI: 10.1099/vir.0.19240-0] [Cited by in Crossref: 77] [Cited by in F6Publishing: 76] [Article Influence: 4.1] [Reference Citation Analysis]
37 Pereira LM, Spinelli V, Ximenes RA, Cavalcanti MS, Melo R, Jucá N, Mizokami M, Mcfarlane IG. Chronic hepatitis C infection: Influence of the viral load, genotypes, and GBV-C/HGV coinfection on the severity of the disease in a Brazilian population: Chronic Hepatitis C Infection. J Med Virol 2002;67:27-32. [DOI: 10.1002/jmv.2188] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
38 Bost-Bru C. [The pediatrician and hepatitis C virus]. Arch Pediatr 1999;6:1122-5. [PMID: 10544791 DOI: 10.1016/s0929-693x(00)86990-0] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
39 Stapleton JT, Klinzman D, Schmidt WN, Pfaller MA, Wu P, Labrecque DR, Han J, Phillips MJP, Woolson R, Alden B. Prospective Comparison of Whole-Blood- and Plasma-Based Hepatitis C Virus RNA Detection Systems: Improved Detection Using Whole Blood as the Source of Viral RNA. J Clin Microbiol 1999;37:484-9. [DOI: 10.1128/jcm.37.3.484-489.1999] [Cited by in Crossref: 36] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
40 Mrani S, Chemin I, Menouar K, Guillaud O, Pradat P, Borghi G, Trabaud MA, Chevallier P, Chevallier M, Zoulim F. Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C. J Med Virol. 2007;79:1075-1081. [PMID: 17596829 DOI: 10.1002/jmv.20943] [Cited by in Crossref: 62] [Cited by in F6Publishing: 66] [Article Influence: 4.1] [Reference Citation Analysis]
41 Hofgärtner WT, Polyak SJ, Sullivan DG, Carithers RL Jr, Gretch DR. Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b. J Med Virol 1997;53:118-26. [PMID: 9334922 DOI: 10.1002/(sici)1096-9071(199710)53:2<118::aid-jmv3>3.0.co;2-c] [Cited by in Crossref: 84] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
42 Geller SA, Nichols WS, Rojter SE, Chan RC, Petrovic LM, Vierling JM, Makowka L. Hepatitis C virus is not recoverable from liver tissue in cryptogenic cirrhosis: failure to identify hepatitis C virus-RNA using reverse transcription-mediated polymerase chain reaction. Hum Pathol 1996;27:1161-5. [PMID: 8912825 DOI: 10.1016/s0046-8177(96)90309-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
43 Bizollon T, Guichard S, Ahmed SN, Chevallier P, Ducerf C, Sepetjan M, Baulieux J, Trepo C. Impact of hepatitis G virus co-infection on the course of hepatitis C virus infection before and after liver transplantation. J Hepatol. 1998;29:893-900. [PMID: 9875635 DOI: 10.1016/S0168-8278(98)80116-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
44 Loriot MA, Bronowicki JP, Lagorce D, Lakehal F, Persico T, Barba G, Mergey M, Vons C, Franco D, Belghiti J. Permissiveness of human biliary epithelial cells to infection by hepatitis C virus. Hepatology. 1999;29:1587-1595. [PMID: 10216147 DOI: 10.1002/hep.510290527] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 1.7] [Reference Citation Analysis]
45 Tsai SL, Chen YM, Chen MH, Huang CY, Sheen IS, Yeh CT, Huang JH, Kuo GC, Liaw YF. Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity. Gastroenterology. 1998;115:954-965. [PMID: 9753499 DOI: 10.1016/s0016-5085(98)70268-9] [Cited by in Crossref: 104] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
46 Aljumah AA, Saeed MA, Al Flaiw AI, Al Traif IH, Al Alwan AM, Al Qurashi SH, Al Ghamdi GA, Al Hejaili FF, Al Balwi MA, Al Sayyari AA. Efficacy and safety of treatment of hepatitis C virus infection in renal transplant recipients. World J Gastroenterol 2012; 18(1): 55-63 [PMID: 22228971 DOI: 10.3748/wjg.v18.i1.55] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
47 Tibbs C. Hepatitis C. Transactions of the Royal Society of Tropical Medicine and Hygiene 1997;91:121-4. [DOI: 10.1016/s0035-9203(97)90191-7] [Cited by in Crossref: 11] [Article Influence: 0.4] [Reference Citation Analysis]
48 Dalagiorgou G, Vassilaki N, Foka P, Boumlic A, Kakkanas A, Kochlios E, Khalili S, Aslanoglou E, Veletza S, Orfanoudakis G, Vassilopoulos D, Hadziyannis SJ, Koskinas J, Mavromara P. High levels of HCV core+1 antibodies in HCV patients with hepatocellular carcinoma. Journal of General Virology 2011;92:1343-51. [DOI: 10.1099/vir.0.023010-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
49 Fukuma T, Enomoto N, Marumo F, Sato C. Mutations in the interferon-sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region 5A protein. Hepatology 1998;28:1147-53. [DOI: 10.1002/hep.510280433] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 1.8] [Reference Citation Analysis]
50 Bell H, Hellum K, Harthug S, Mæland A, Ritland S, Myrvang B, Von Der Lippe B, Raknerud N, Skaug K, Prescott L, Simmonds P. Prevalence of Hepatitis C Genotypes among Patients with Chronic Hepatitis C in Norway. Scandinavian Journal of Infectious Diseases 2009;28:357-9. [DOI: 10.3109/00365549609037919] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
51 Zoulim F, Chevallier M, Maynard M, Trepo C. Clinical consequences of hepatitis C virus infection. Rev Med Virol. 2003;13:57-68. [PMID: 12516062 DOI: 10.1002/rmv.371] [Cited by in Crossref: 82] [Cited by in F6Publishing: 77] [Article Influence: 4.3] [Reference Citation Analysis]
52 Grahovac B, Bingulac-popovic J, Vucelic B, Hrstic I, Ostojic R, Drazic V, Balija M, Grgicevic D. Dynamics of serum hepatitis C virus load and quasispecies complexity during antiviral therapy in patients with chronic hepatitis C. Journal of Clinical Virology 2001;20:85-9. [DOI: 10.1016/s1386-6532(00)00160-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
53 Silva CMDD, Costi C, Krug LP, Ramos AB, Grandi T, Gandolfi VL, Menezes ME, Ocampos M, Niel C, Rossetti MLR. High proportion of hepatitis C virus genotypes 1 and 3 in a large cohort of patients from Southern Brazil. Mem Inst Oswaldo Cruz 2007;102:867-70. [DOI: 10.1590/s0074-02762007005000122] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
54 Fujita N, Kaito M, Takeo M, Iwasa M, Ikoma J, Watanabe S, Adachi Y. Nonimmune Complexed HCV RNA Titer in Serum as a Predictor of Interferon Response in Patients With Chronic Hepatitis C. Am J Gastroenterology 2003;98:645-52. [DOI: 10.1111/j.1572-0241.2003.07330.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
55 Fan X, Bisceglie AM. Genetic complexity and serum reactivity of HVR1 quasispecies of hepatitis C virus in patients with cirrhosis. Am J Gastroenterology 2002;97:1489-95. [DOI: 10.1111/j.1572-0241.2002.05794.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
56 Pestova TV, Hellen CU. Internal initiation of translation of bovine viral diarrhea virus RNA. Virology. 1999;258:249-256. [PMID: 10366562 DOI: 10.1006/viro.1999.9741] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 1.9] [Reference Citation Analysis]
57 Anderson JC, Simonetti J, Fisher DG, Williams J, Yamamura Y, Rodriguez N, Sullivan DG, Gretch DR, McMahon B, Williams KJ. Comparison of different HCV viral load and genotyping assays. J Clin Virol. 2003;28:27-37. [PMID: 12927748 DOI: 10.1016/s1386-6532(02)00235-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
58 Touceda S, Pereira M, Agulla A. [Prevalence of hepatitis C virus genotypes in the area of El Ferrol (La Coruña, Spain)]. Enferm Infecc Microbiol Clin 2002;20:200-4. [PMID: 12006256 DOI: 10.1016/s0213-005x(02)72789-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
59 Linnen JM, Gilker J, Menez A, Vaughn A, Broulik A, Dockter J, Gillotte-taylor K, Greenbaum K, Kolk DP, Mimms LT, Giachetti C. Sensitive detection of genetic variants of HIV-1 and HCV with an HIV-1/HCV assay based on transcription-mediated amplification. Journal of Virological Methods 2002;102:139-55. [DOI: 10.1016/s0166-0934(02)00012-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
60 Yun Z, Lara C, Johansson B, Lorenzana de Rivera I, Sönnerborg A. Discrepancy of hepatitis C virus genotypes as determined by phylogenetic analysis of partial NS5 and core sequences. J Med Virol 1996;49:155-60. [PMID: 8818959 DOI: 10.1002/(SICI)1096-9071(199607)49:3<155::AID-JMV1>3.0.CO;2-3] [Cited by in Crossref: 39] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
61 Morel V, Duverlie G, Brochot E. Patients eligible for treatment with simeprevir in a French center. J Clin Virol 2014;61:149-51. [PMID: 25027573 DOI: 10.1016/j.jcv.2014.06.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
62 Hjalmarsson S, Blomberg J, Grillner L, Pipkorn R, Allander T. Sequence evolution and cross-reactive antibody responses to hypervariable region 1 in acute hepatitis C virus infection. J Med Virol. 2001;64:117-124. [PMID: 11360243 DOI: 10.1002/jmv.1026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
63 Bortolotti F, Resti M, Giacchino R, Crivellaro C, Zancan L, Azzari C, Gussetti N, Tasso L, Faggion S. Changing epidemiologic pattern of chronic hepatitis C virus infection in Italian children. J Pediatr. 1998;133:378-381. [PMID: 9738720 DOI: 10.1016/s0022-3476(98)70273-2] [Cited by in Crossref: 54] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
64 Amoroso P, Rapicetta M, Tosti ME, Mele A, Spada E, Buonocore S, Lettieri G, Pierri P, Chionne P, Ciccaglione AR, Sagliocca L. Correlation between virus genotype and chronicity rate in acute hepatitis C. Journal of Hepatology 1998;28:939-44. [DOI: 10.1016/s0168-8278(98)80340-1] [Cited by in Crossref: 79] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
65 Abdelmalek MF, Firpi RJ, Soldevila-Pico C, Reed AI, Hemming AW, Liu C, Crawford JM, Davis GL, Nelson DR. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C. Liver Transpl. 2004;10:199-207. [PMID: 14762857 DOI: 10.1002/lt.20074] [Cited by in Crossref: 124] [Cited by in F6Publishing: 112] [Article Influence: 6.9] [Reference Citation Analysis]
66 Kim YJ, Kim S, Chung HJ, Jee MS, Kim BG, Kim KM, Yoon J, Lee H, Kim CY, Kim S, Yoo W, Hong SP. Population Genotyping of Hepatitis C Virus by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Analysis of Short DNA Fragments. Clinical Chemistry 2005;51:1123-31. [DOI: 10.1373/clinchem.2004.047506] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
67 Bronowicki JP, Loriot MA, Thiers V, Grignon Y, Zignego AL, Bréchot C. Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice. Hepatology 1998;28:211-8. [PMID: 9657114 DOI: 10.1002/hep.510280127] [Cited by in Crossref: 76] [Cited by in F6Publishing: 77] [Article Influence: 3.2] [Reference Citation Analysis]
68 Mondelli MU, Silini E. Clinical significance of hepatitis C virus genotypes. Journal of Hepatology 1999;31:65-70. [DOI: 10.1016/s0168-8278(99)80377-8] [Cited by in Crossref: 67] [Cited by in F6Publishing: 14] [Article Influence: 2.9] [Reference Citation Analysis]
69 Altuglu I, Soyler I, Ozacar T, Erensoy S. Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C infection in Western Turkey. Int J Infect Dis 2008;12:239-44. [PMID: 17942359 DOI: 10.1016/j.ijid.2007.07.003] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
70 Martinot-Peignoux M, Roudot-Thoraval F, Mendel I, Coste J, Izopet J, Duverlie G, Payan C, Pawlotsky JM, Defer C, Bogard M. Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy. The GEMHEP. J Viral Hepat. 1999;6:435-443. [PMID: 10607261 DOI: 10.1046/j.1365-2893.1999.00187.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 71] [Article Influence: 3.2] [Reference Citation Analysis]
71 Castelain S, Zawadzki P, Khorsi H, Darchis J, Capron D, Sueur J, Eb F, Duverlie G. Comparison of hepatitis C virus serotyping and genotyping in French patients. Clinical and Diagnostic Virology 1997;7:159-65. [DOI: 10.1016/s0928-0197(96)00266-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
72 Berry N, Chakravarti A, Das U, Kar P, Das BC, Mathur MD. HCV seroreactivity and detection of HCV RNA in cirrhotics. Diagn Microbiol Infect Dis 1999;35:209-13. [PMID: 10626131 DOI: 10.1016/s0732-8893(99)00091-7] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
73 Donadel E, Pontisso P, Ruvoletto MG, Gerotto M, De Salvo G, Chemello L, Casarin C, Alberti A. Characteristics of hepatitis C virus before and after interferon treatment in patients with ongoing viraemia but sustained biochemical response. J Med Virol 1998;54:7-11. [DOI: 10.1002/(sici)1096-9071(199801)54:1<7::aid-jmv2>3.0.co;2-b] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
74 Ramia S, Eid-Fares J. Distribution of hepatitis C virus genotypes in the Middle East. Int J Infect Dis 2006;10:272-7. [PMID: 16564719 DOI: 10.1016/j.ijid.2005.07.008] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 4.3] [Reference Citation Analysis]
75 Pearlman BL. Hepatitis C treatment update. The American Journal of Medicine 2004;117:344-52. [DOI: 10.1016/j.amjmed.2004.03.024] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 3.2] [Reference Citation Analysis]
76 Zhou J, Su J, Chen H, Zhang J, Ma L, Ding Y, Stipkovits L, Szathmary S, Pejsak Z, Liu Y. Clustering of low usage codons in the translation initiation region of hepatitis C virus. Infection, Genetics and Evolution 2013;18:8-12. [DOI: 10.1016/j.meegid.2013.03.043] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
77 Nakao H, Okamoto H, Fukuda M, Tsuda F, Mitsui T, Masuko K, Iizuka H, Miyakawa Y, Mayumi M. Mutation rate of GB virus C/hepatitis G virus over the entire genome and in subgenomic regions. Virology 1997;233:43-50. [PMID: 9201215 DOI: 10.1006/viro.1997.8615] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 2.3] [Reference Citation Analysis]
78 Li D, Takyar ST, Lott WB, Gowans EJ. Amino acids 1-20 of the hepatitis C virus (HCV) core protein specifically inhibit HCV IRES-dependent translation in HepG2 cells, and inhibit both HCV IRES- and cap-dependent translation in HuH7 and CV-1 cells. J Gen Virol. 2003;84:815-825. [PMID: 12655082 DOI: 10.1099/vir.0.18697-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 1.7] [Reference Citation Analysis]
79 Dong Y, Qiu C, Xia X, Wang J, Zhang H, Zhang X, Xu J. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study. Arch Virol 2015;160:929-36. [PMID: 25616842 DOI: 10.1007/s00705-014-2311-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
80 Dammacco F, Sansonno D. Mixed cryoglobulinemia as a model of systemic vasculitis. Clinic Rev Allerg Immunol 1997;15:97-119. [DOI: 10.1007/bf02828280] [Cited by in Crossref: 27] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
81 Svoboda-newman SM, Greenson JK, Singleton TP, Sun R, Frank TS. Detection of Hepatitis C by RT-PCR in Formalin-Fixed Paraffin-Embedded Tissue from Liver Transplant Patients: . Diagnostic Molecular Pathology 1997;6:123. [DOI: 10.1097/00019606-199704000-00009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
82 Patel AH, Wood J, Penin F, Dubuisson J, McKeating JA. Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding. J Gen Virol 2000;81:2873-83. [PMID: 11086118 DOI: 10.1099/0022-1317-81-12-2873] [Cited by in Crossref: 68] [Cited by in F6Publishing: 67] [Article Influence: 3.2] [Reference Citation Analysis]
83 Martín J, Navas S, Quiroga JA, Colucci G, Pardo M, Carreño V. Quantitation of hepatitis C virus in liver and peripheral blood mononuclear cells from patients with chronic hepatitis C virus infection. J Med Virol 1998;54:265-70. [DOI: 10.1002/(sici)1096-9071(199804)54:4<265::aid-jmv5>3.0.co;2-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
84 Pirisi M, Scott CA, Avellini C, Toniutto P, Fabris C, Soardo G, Beltrami CA, Bartoli E. Iron deposition and progression of disease in chronic hepatitis C. Role of interface hepatitis, portal inflammation, and HFE missense mutations. Am J Clin Pathol. 2000;113:546-554. [PMID: 10761457 DOI: 10.1309/trb1-jxuj-l9r6-9nhx] [Cited by in Crossref: 33] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
85 Clarke BE, Slater MJ. Developments in hepatitis C during 1996 - 1997. Expert Opinion on Therapeutic Patents 2005;7:979-87. [DOI: 10.1517/13543776.7.9.979] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
86 Trivedi M. Newly diagnosed hepatitis C: Lack of symptoms doesn't mean lack of progression. Postgraduate Medicine 2015;102:95-101. [DOI: 10.3810/pgm.1997.12.379] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
87 Sandres-sauné K, Deny P, Pasquier C, Thibaut V, Duverlie G, Izopet J. Determining hepatitis C genotype by analyzing the sequence of the NS5b region. Journal of Virological Methods 2003;109:187-93. [DOI: 10.1016/s0166-0934(03)00070-3] [Cited by in Crossref: 124] [Cited by in F6Publishing: 48] [Article Influence: 6.5] [Reference Citation Analysis]
88 Bréchot C. Hepatitis C virus: Molecular biology and genetic variability. Digest Dis Sci 1996;41:6S-21S. [DOI: 10.1007/bf02087872] [Cited by in Crossref: 40] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
89 Halfon P, Ouzan D, Khiri H, Feryn JM. Serotyping and genotyping of hepatitis C virus (HCV) strains in chronic HCV infection. J Med Virol 1997;52:391-5. [DOI: 10.1002/(sici)1096-9071(199708)52:4<391::aid-jmv8>3.0.co;2-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
90 Buratti E, Gerotto M, Pontisso P, Alberti A, Tisminetzky S, Baralle F. In vivo translational efficiency of different hepatitis C virus 5′-UTRs. FEBS Letters 1997;411:275-80. [DOI: 10.1016/s0014-5793(97)00715-1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
91 Wei L, Wang Y, Chen HS, Tao QM. Sequencing of hepatitis C virus cDNA with polymerase chain reaction directed sequencing. World J Gastroenterol 1997; 3(1): 12-15 [PMID: 27006575 DOI: 10.3748/wjg.v3.i1.12] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
92 Giannini E, Fasoli A, Botta F, Testa E, Romagnoli P, Ceppa P, Testa R. Long-term follow up of chronic hepatitis C patients after alpha-interferon treatment: a functional study. J Gastroenterol Hepatol. 2001;16:399-405. [PMID: 11354278 DOI: 10.1046/j.1440-1746.2001.02463.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
93 Berk PD. An editor's look-back. Hepatology 2006;43:S13-30. [PMID: 16447279 DOI: 10.1002/hep.21056] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
94 Ray SC, Thomas DL. Hepatitis C. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Elsevier; 2010. pp. 2157-85. [DOI: 10.1016/b978-0-443-06839-3.00154-5] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
95 Jacobson Brown PM, Neuman MG. Immunopathogenesis of hepatitis C viral infection: Th1/Th2 responses and the role of cytokines. ClinBiochem. 2001;34:167-171. [PMID: 11408013 DOI: 10.1016/s0009-9120(01)00210-7] [Cited by in Crossref: 64] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
96 Yang JH, Lai JP, Douglas SD, Metzger D, Zhu XH, Ho WZ. Real-time RT-PCR for quantitation of hepatitis C virus RNA. J Virol Methods. 2002;102:119-128. [PMID: 11879700 DOI: 10.1016/s0166-0934(02)00007-1] [Cited by in Crossref: 63] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
97 Bréchot C. [Biology of hepatitis C viruses: clinical implications]. Rev Med Interne 1997;18:893-905. [PMID: 9499991 DOI: 10.1016/s0248-8663(97)81964-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
98 Fried MW. CLINICAL APPLICATION OF HEPATITIS C VIRUS GENOTYPING AND QUANTITATION. Clinics in Liver Disease 1997;1:631-46. [DOI: 10.1016/s1089-3261(05)70326-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
99 Dienstag JL, McHutchison JG. American Gastroenterological Association technical review on the management of hepatitis C. Gastroenterology. 2006;130:231-264; quiz 214-217. [PMID: 16401486 DOI: 10.1053/j.gastro.2005.11.010] [Cited by in Crossref: 261] [Cited by in F6Publishing: 246] [Article Influence: 16.3] [Reference Citation Analysis]
100 Da Rocha Gomes S, Dausse E, Toulmé J. Determinants of apical loop–internal loop RNA–RNA interactions involving the HCV IRES. Biochemical and Biophysical Research Communications 2004;322:820-6. [DOI: 10.1016/j.bbrc.2004.07.185] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
101 Bostan N, Mahmood T. An overview about hepatitis C: a devastating virus. Crit Rev Microbiol. 2010;36:91-133. [PMID: 20345213 DOI: 10.3109/10408410903357455] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 6.1] [Reference Citation Analysis]
102 Petrik J, Pearson GJ, Allain J. High throughput PCR detection of HCV based on semiautomated multisample RNA capture. Journal of Virological Methods 1997;64:147-59. [DOI: 10.1016/s0166-0934(96)02153-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
103 Esteban JI, Martell M, Carman WF, Gómez J. The Impact of Rapid Evolution of the Hepatitis Viruses. Origin and Evolution of Viruses. Elsevier; 1999. pp. 345-76. [DOI: 10.1016/b978-012220360-2/50014-3] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
104 Chang J, Seidel C, Ofenloch B, Jue D, Fields H, Khudyakov Y. Antigenic Heterogeneity of the Hepatitis C Virus NS4 Protein as Modeled with Synthetic Peptides. Virology 1999;257:177-90. [DOI: 10.1006/viro.1999.9612] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
105 Tamalet C, Colson P, Tissot-dupont H, Henry M, Tourres C, Tivoli N, Botta D, Ravaux I, Poizot-martin I, Yahi N. Genomic and phylogenetic analysis of hepatitis C virus isolates: A survey of 535 strains circulating in southern France. J Med Virol 2003;71:391-8. [DOI: 10.1002/jmv.10505] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
106 Collier J, Heathcote J. Hepatitis C viral infection in the immunosuppressed patient. Hepatology 1998;27:2-6. [DOI: 10.1002/hep.510270102] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 2.2] [Reference Citation Analysis]
107 Leone F, Zylberberg H, Squadrito G, Le Guen B, Berthelot P, Pol S, Brechot C. Hepatitis C virus (HCV) hypervariable region 1 complexity does not correlate with severity of liver disease, HCV type, viral load or duration of infection. Journal of Hepatology 1998;29:689-94. [DOI: 10.1016/s0168-8278(98)80247-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
108 Fishman JA, Rubin RH, Koziel MJ, Periera BJG. HEPATITIS C VIRUS AND ORGAN TRANSPLANTATION: . Transplantation 1996;62:147-54. [DOI: 10.1097/00007890-199607270-00001] [Cited by in Crossref: 90] [Cited by in F6Publishing: 74] [Article Influence: 3.5] [Reference Citation Analysis]
109 Hwang SJ, Lee SD, Lu RH, Chu CW, Wu JC, Lai ST, Chang FY. Hepatitis C viral genotype influences the clinical outcome of patients with acute posttransfusion hepatitis C. J Med Virol. 2001;65:505-509. [PMID: 11596085 DOI: 10.1002/jmv.2064] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
110 Dentico P, Curatolo N, Sacco R, De Luca M, Volpe A, Ranieri C, Genchi C, Petracca L, Buongiorno R. Hepatitis C virus serotypes and sources of infection in patients with HCV-related chronic liver disease from one geographical Area in southeast Italy. Infection 1999;27:118-21. [DOI: 10.1007/bf02560510] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
111 Bizollon T, Adham M, Pradat P, Chevallier M, Ducerf C, Baulieux J, Zoulim F, Trepo C. Triple Antiviral Therapy with Amantadine for IFN-Ribavirin Nonresponders with Recurrent Posttransplantation Hepatitis C. Transplantation 2005;79:325-9. [DOI: 10.1097/01.tp.0000149499.78996.b3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
112 Asti M, Martinetti M, Zavaglia C, Cuccia MC, Gusberti L, Tinelli C, Cividini A, Bruno S, Salvaneschi L, Ideo G. Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease. Hepatology. 1999;29:1272-1279. [PMID: 10094975 DOI: 10.1002/hep.510290445] [Cited by in Crossref: 67] [Cited by in F6Publishing: 68] [Article Influence: 2.9] [Reference Citation Analysis]
113 Morales JM, Campistol JM, Andrés A, Rodicio JL. Hepatitis C virus and renal transplantation. Curr Opin Nephrol Hypertens 1998;7:177-83. [PMID: 9529620 DOI: 10.1097/00041552-199803000-00006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
114 Ahmed A, Keeffe EB. Hepatitis C virus and liver transplantation. Clin Liver Dis. 2001;5:1073-1090. [PMID: 11685796 DOI: 10.1016/s1089-3261(05)70210-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
115 Ferrari C, Urbani S, Penna A, Cavalli A, Valli A, Lamonaca V, Bertoni R, Boni C, Barbieri K, Uggeri J, Fiaccadori F. Immunopathogenesis of hepatitis C virus infection. J Hepatol 1999;31 Suppl 1:31-8. [PMID: 10622557 DOI: 10.1016/s0168-8278(99)80371-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
116 Kobayashi M, Akuta N, Suzuki F, Hosaka T, Sezaki H, Kobayashi M, Suzuki Y, Arase Y, Ikeda K, Watahiki S, Mineta R, Iwasaki S, Miyakawa Y, Kumada H. Influence of amino-acid polymorphism in the core protein on progression of liver disease in patients infected with hepatitis C virus genotype 1b. J Med Virol 2010;82:41-8. [DOI: 10.1002/jmv.21629] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
117 Mazza C, Puoti M, Ravaggi A, Castelnuovo F, Albertini A, Cariani E. Molecular analysis of mixed infection with hepatitis C virus and human immunodeficiency virus in a patient infected simultaneously. J Med Virol 1996;50:276-82. [DOI: 10.1002/(sici)1096-9071(199611)50:3<276::aid-jmv11>3.0.co;2-i] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
118 Cong M, Fried MW, Lambert S, Lopareva EN, Zhan M, Pujol FH, Thyagarajan SP, Byun KS, Fields HA, Khudyakov YE. Sequence heterogeneity within three different regions of the hepatitis G virus genome. Virology 1999;255:250-9. [PMID: 10069950 DOI: 10.1006/viro.1998.9592] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
119 Sarih M, Bouchrit N, Benslimane A. Different cytokine profiles of peripheral blood mononuclear cells from patients with persistent and self-limited hepatitis C virus infection. Immunol Lett. 2000;74:117-120. [PMID: 10996386 DOI: 10.1016/s0165-2478(00)00210-8] [Cited by in Crossref: 44] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
120 Alberti A. Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: A pragmatic study. Liver Transplantation 2001;7:870-6. [DOI: 10.1053/jlts.2001.27871] [Cited by in Crossref: 76] [Cited by in F6Publishing: 63] [Article Influence: 3.6] [Reference Citation Analysis]
121 Germer JJ, Zein NN. Advances in the molecular diagnosis of hepatitis C and their clinical implications. Mayo Clin Proc. 2001;76:911-920. [PMID: 11560302 DOI: 10.1016/s0025-6196(11)62111-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
122 Irshad M, Mankotia DS, Irshad K. An insight into the diagnosis and pathogenesis of hepatitis C virus infection. World J Gastroenterol 2013; 19(44): 7896-7909 [PMID: 24307784 DOI: 10.3748/wjg.v19.i44.7896] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
123 Sugiyama K, Goto K, Miyake Y, Ando T, Oda T, Maniwa H, Li R, Kawabe Y, Wada Y. Analysis of the Hypervariable Region of Hepatitis C Virus E2/NS1 Gene in an Infant Infected by Blood Transfusion. Pediatr Res 1997;42:247-50. [DOI: 10.1203/00006450-199708000-00020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
124 Stamenkovic G, Guduric J, Velickovic Z, Skerl V, Krtolica K, Veljkovic E, Dimitrijevic B. Analysis of 5' non-coding region in hepatitis C virus by single-strand conformation polymorphism and low-stringency single specific primer PCR. Clin Chem Lab Med 2001;39:948-52. [PMID: 11758608 DOI: 10.1515/CCLM.2001.152] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
125 Nita ME, Alves VA, Carrilho FJ, Ono-Nita SK, Mello ES, Gama-Rodrigues JJ. Molecular aspects of hepatic carcinogenesis. Rev Inst Med Trop Sao Paulo. 2002;44:39-48. [PMID: 11896411 DOI: 10.1590/s0036-46652002000100007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
126 Hiraga N, Suzuki F, Akuta N, Suzuki Y, Sezaki H, Hosaka T, Someya T, Kobayashi M, Saitoh S, Arase Y. Clinical and virological characteristics of untreated patients with chronic hepatitis C who develop serum alanine aminotransferase flare-up. J Med Virol. 2005;75:240-248. [PMID: 15602722 DOI: 10.1002/jmv.20263] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
127 Soriano V, Rodríguez-rosado R, García-samaniego J. Management of chronic hepatitis C in HIV-infected patients: . AIDS 1999;13:539-46. [DOI: 10.1097/00002030-199904010-00002] [Cited by in Crossref: 76] [Cited by in F6Publishing: 72] [Article Influence: 3.3] [Reference Citation Analysis]
128 Zoulim F. Quantification and genotyping in management of chronic hepatitis B and C. Virus Res 2002;82:45-52. [PMID: 11885949 DOI: 10.1016/s0168-1702(01)00386-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
129 Nozaki A, Ikeda M, Naganuma A, Nakamura T, Inudoh M, Tanaka K, Kato N. Identification of a Lactoferrin-derived Peptide Possessing Binding Activity to Hepatitis C Virus E2 Envelope Protein. Journal of Biological Chemistry 2003;278:10162-73. [DOI: 10.1074/jbc.m207879200] [Cited by in Crossref: 41] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
130 Perone C, Del Castillo DM, Pereira GL, Carvalho Nde O, Januário JN, Teixeira R. [High prevalence of genotype 1 in individuals with hepatitis C in Belo Horizonte, MG]. Rev Soc Bras Med Trop 2008;41:238-42. [PMID: 18719801 DOI: 10.1590/s0037-86822008000300003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
131 van Doorn L, van Hoek K, de Martinoff G, Bosman F, Stuyver L, Kos T, Frantzen I, Sillekens P, Maertens G, Quint W. Serological and molecular analysis of hepatitis C virus envelope regions 1 and 2 during acute and chronic infections in chimpanzees. J Med Virol 1997;52:441-50. [DOI: 10.1002/(sici)1096-9071(199708)52:4<441::aid-jmv17>3.0.co;2-j] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
132 Muir P, Kämmerer U, Korn K, Mulders MN, Pöyry T, Weissbrich B, Kandolf R, Cleator GM, van Loon AM. Molecular Typing of Enteroviruses: Current Status and Future Requirements. Clin Microbiol Rev 1998;11:202-27. [DOI: 10.1128/cmr.11.1.202] [Cited by in Crossref: 182] [Cited by in F6Publishing: 65] [Article Influence: 7.6] [Reference Citation Analysis]
133 Bell H, Hellum K, Harthug S, Mæland A, Ritland S, Myrvang B, Von Der Lippe B, Raknerud N, Skaug K, Gutigard B, Skjærven R, Prescott LE, Simmonds P. Genotype, Viral Load and Age as Independent Predictors of Treatment Outcome of Interferon-α2a Treatment in Patients with Chronic Hepatitis C. Scandinavian Journal of Infectious Diseases 2009;29:17-22. [DOI: 10.3109/00365549709008658] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
134 Fabrizi F, Martin P, Lunghi G, Ponticelli C. Nosocomial Transmission of Hepatitis C virus Infection in Hemodialysis Patients: Clinical Perspectives. Int J Artif Organs 2000;23:805-16. [DOI: 10.1177/039139880002301205] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
135 Mas A, Ulloa E, Bruguera M, Furčić I, Garriga D, Fábregas S, Andreu D, Saiz JC, Díez J. Hepatitis C virus population analysis of a single-source nosocomial outbreak reveals an inverse correlation between viral load and quasispecies complexity. Journal of General Virology 2004;85:3619-26. [DOI: 10.1099/vir.0.80500-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
136 Soriuno V, Bravo R, Garcia-samaniego J, Castro A, Carballo E, González-anglada I, Martinez-odriozola P, Colmenero M, Pedreira J. Circulating Hepatitis C Virus Genotypes in Spain. Vox Sanguinis 1996;70:180-1. [DOI: 10.1111/j.1423-0410.1996.tb01320.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
137 Gretch DR. USE AND INTERPRETATION OF HCV DIAGNOSTIC TESTS IN THE CLINICAL SETTING. Clinics in Liver Disease 1997;1:543-57. [DOI: 10.1016/s1089-3261(05)70320-2] [Cited by in Crossref: 23] [Article Influence: 0.9] [Reference Citation Analysis]
138 Fang JW, Chow V, Lau JY. VIROLOGY OF HEPATITIS C VIRUS. Clinics in Liver Disease 1997;1:493-514. [DOI: 10.1016/s1089-3261(05)70317-2] [Cited by in Crossref: 18] [Article Influence: 0.7] [Reference Citation Analysis]
139 Roth D, Zucker K, Cirocco R, Burke G, Ciancio G, Esquenazi V, Swanson SJ 3rd, Miller J. A prospective study of hepatitis C virus infection in renal allograft recipients. Transplantation 1996;61:886-9. [PMID: 8623154 DOI: 10.1097/00007890-199603270-00007] [Cited by in Crossref: 88] [Cited by in F6Publishing: 77] [Article Influence: 3.4] [Reference Citation Analysis]
140 Aljumah AA, Murad MH. Pegylated versus standard interferon plus ribavirin in chronic hepatitis C genotype 4: A systematic review and meta-analysis: PEG IFN vs IFN in hepatitis C genotype 4. Hepatol Res 2013;43:1255-63. [DOI: 10.1111/hepr.12084] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
141 Ferrari C, Penna A, Bertoletti A, Cavalli A, Missale G, Lamonaca V, Boni C, Valli A, Bertoni R, Urbani S, Scognamiglio P, Fiaccadori F. Antiviral Cell-Mediated Immune Responses During Hepatitis B and Hepatitis C Virus Infections. In: Schwab M, Rabes HM, Munk K, Hofschneider HP, editors. Genes and Environment in Cancer. Berlin: Springer Berlin Heidelberg; 1998. pp. 330-6. [DOI: 10.1007/978-3-642-46870-4_24] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 0.9] [Reference Citation Analysis]
142 Chinchai T, Labout J, Noppornpanth S, Theamboonlers A, Haagmans BL, Osterhaus AD, Poovorawan Y. Comparative study of different methods to genotype hepatitis C virus type 6 variants. J Virol Methods. 2003;109:195-201. [PMID: 12711063 DOI: 10.1016/s0166-0934(03)00071-5] [Cited by in Crossref: 44] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
143 Lutwick LI. Postexposure prophylaxis. Infect Dis Clin North Am 1996;10:899-915. [PMID: 8958174 DOI: 10.1016/s0891-5520(05)70332-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
144 Mellor J, Walsh EA, Prescott LE, Jarvis LM, Davidson F, Yap PL, Simmonds P. Survey of type 6 group variants of hepatitis C virus in Southeast Asia by using a core-based genotyping assay. J Clin Microbiol 1996;34:417-23. [DOI: 10.1128/jcm.34.2.417-423.1996] [Cited by in Crossref: 88] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
145 Nakano I, Fukuda Y, Katano Y, Nakano S, Kumada T, Hayakawa T. Why is the interferon sensitivity-determining region (ISDR) system useful in Japan? J Hepatol. 1999;30:1014-1022. [PMID: 10406178 DOI: 10.1016/s0168-8278(99)80254-2] [Cited by in Crossref: 47] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
146 Welch PJ, Yei S, Barber JR. Ribozyme gene therapy for hepatitis C virus infection. Clin Diagn Virol. 1998;10:163-171. [PMID: 9741642 DOI: 10.1016/s0928-0197(98)00029-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
147 Pawlotsky JM. Hepatitis C virus resistance to antiviral therapy. Hepatology 2000;32:889-96. [PMID: 11050035 DOI: 10.1053/jhep.2000.19150] [Cited by in Crossref: 96] [Cited by in F6Publishing: 95] [Article Influence: 4.4] [Reference Citation Analysis]
148 craxì A, Di Marco V, Cammà C, Almasio P, Magrin S. Duration of HCV infection as a predictor of nonresponse to interferon. Digest Dis Sci 1996;41:86S-92S. [DOI: 10.1007/bf02087881] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
149 Nagao Y, Sata M, Abe K, Tanikawa K, Kameyama T. Immunological evaluation in oral lichen planus with chronic hepatitis C. J Gastroenterol 1997;32:324-9. [DOI: 10.1007/bf02934488] [Cited by in Crossref: 21] [Article Influence: 0.8] [Reference Citation Analysis]
150 Bendinelli M, Vatteroni ML, Maggi F, Pistello M. Hepatitis C Virus. In: Specter S, editor. Viral Hepatitis. Totowa: Humana Press; 1999. pp. 65-127. [DOI: 10.1007/978-1-59259-702-4_4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
151 Koshy R, Inchauspé G. Evaluation of hepatitis C virus protein epitopes for vaccine development. Trends Biotechnol. 1996;14:364-369. [PMID: 8987634 DOI: 10.1016/0167-7799(96)10049-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
152 Kusalik A, Bickis M, Lewis C, Li Y, Lucchese G, Marincola FM, Kanduc D. Widespread and ample peptide overlapping between HCV and Homo sapiens proteomes. Peptides 2007;28:1260-7. [PMID: 17485143 DOI: 10.1016/j.peptides.2007.04.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
153 Azzari C, Resti M, Bortolotti F, Moriondo M, Crivellaro C, Lionetti P, Vierucci A. Serum Levels of Hepatitis C Virus RNA in Infants and Children with Chronic Hepatitis C: . Journal of Pediatric Gastroenterology & Nutrition 1999;29:314-7. [DOI: 10.1097/00005176-199909000-00014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
154 Fonseca SG, Moins-Teisserenc H, Clave E, Ianni B, Nunes VL, Mady C, Iwai LK, Sette A, Sidney J, Marin ML. Identification of multiple HLA-A*0201-restricted cruzipain and FL-160 CD8+ epitopes recognized by T cells from chronically Trypanosoma cruzi-infected patients. Microbes Infect. 2005;7:688-697. [PMID: 15848276 DOI: 10.1016/j.micinf.2005.01.001] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 3.1] [Reference Citation Analysis]
155 Lamonaca V, Missale G, Urbani S, Pilli M, Boni C, Mori C, Sette A, Massari M, Southwood S, Bertoni R. Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine development. Hepatology. 1999;30:1088-1098. [PMID: 10498664 DOI: 10.1002/hep.510300435] [Cited by in Crossref: 102] [Cited by in F6Publishing: 96] [Article Influence: 4.4] [Reference Citation Analysis]
156 Rosen HR, Martin P. Viral hepatitis in the liver transplant recipient. Infect Dis Clin North Am 2000;14:761-84. [PMID: 10987119 DOI: 10.1016/s0891-5520(05)70130-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
157 García-monzón C, Jara P, Fernández-bermejo M, Hierro L, Frauca E, Camarena C, Díaz C, De la Vega A, Larrauri J, García-iglesias C, Borque MJ, Sanz P, García-buey L, Moreno-monteagudo JA, Moreno-otero R. Chronic hepatitis C in children: A clinical and immunohistochemical comparative study with adult patients: Chronic Hepatitis C in Children: A Clinical and Immunohistochemical Comparative Study With Adult Patients. Hepatology 1998;28:1696-701. [DOI: 10.1002/hep.510280633] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 2.9] [Reference Citation Analysis]
158 Pár A, Gervain J, Gógl A. Hepatitis C virus infection: pathogenesis, diagnosis and treatment. Scand J Gastroenterol Suppl 1998;228:107-14. [PMID: 9867120 DOI: 10.1080/003655298750026633] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
159 Yu M, Wang L, Chuang W, Dai C, Sung M, Chen S, Lin Z, Hsieh M, Tsai J, Chang W. Serotyping and genotyping of hepatitis C virus in Taiwanese patients with type C chronic liver disease and uraemic patients on maintenance haemodialysis. Journal of Gastroenterology and Hepatology 2001;15:792-7. [DOI: 10.1046/j.1440-1746.2000.02195.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
160 Ferraro D, Genovese D, Argentini C, Giordano V, Pizzillo P, Stroffolini T, Craxì A, Rapicetta M, Di Stefano R. Phylogenetic reconstruction of HCV genotype 1b dissemination in a small city centre: The Camporeale model. J Med Virol 2008;80:1723-31. [DOI: 10.1002/jmv.21276] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
161 Zhang L, Zhao GZ, Li Y, Shi LL. Dynamic changes of HVR1 quasispecies in chronic hepatitis C after IFN therapy. Shijie Huaren Xiaohua Zazhi 2003; 11(2): 182-184 [DOI: 10.11569/wcjd.v11.i2.182] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
162 Naoumov NV, Chokshi S, Metivier E, Maertens G, Johnson PJ, Williams R. Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis. Journal of Hepatology 1997;27:331-6. [DOI: 10.1016/s0168-8278(97)80179-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
163 Siciliano R, Carrá R, Elia G, Rosso D, Santancelo N, Trovato BA, Giunta E, Cutrona D. Chronic hepatitis C in elderly patients: clinical, histological and virological features. Arch Gerontol Geriatr 1996;22 Suppl 1:327-33. [PMID: 18653052 DOI: 10.1016/0167-4943(96)86957-3] [Reference Citation Analysis]
164 García F, Roldàn C, Hernàndez-quero J, Bernal MC, Martínez MA, López MA, Piédrola G, Maroto MC. Relationship between viral genotype and viral load in patients with chronic hepatitis C. Eur J Clin Microbiol Infect Dis 1996;15:884-7. [DOI: 10.1007/bf01691224] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
165 Seme K, Poljak M, Les˘nic˘ar G, Brinovec V, S˘tepec S, Koren S. Distribution of Hepatitis C Virus Genotypes in Slovenia. Scandinavian Journal of Infectious Diseases 2009;29:29-31. [DOI: 10.3109/00365549709008660] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
166 Lin R, Saab S. The Current Status of Hepatitis C. Int J Artif Organs 2001;24:838-42. [DOI: 10.1177/039139880102401208] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
167 Dhaliwal S, Prescott L, Dow B, Davidson F, Brown H, Yap P, Follett E, Simmonds P. Influence of viraemia and genotype upon serological reactivity in screening assays for antibody to hepatitis C virus. J Med Virol 1996;48:184-90. [DOI: 10.1002/(sici)1096-9071(199602)48:2<184::aid-jmv11>3.0.co;2-f] [Cited by in Crossref: 36] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
168 Toniutto P, Pirisi M, Tisminetzky SG, Fabris C, Chinellato E, Gerotto M, Falleti E, Ferroni P, Lombardelli T, Bartoli E, Baralle F. Discordant results from hepatitis C virus genotyping by procedures based on amplification of different genomic regions. J Clin Microbiol 1996;34:2382-5. [DOI: 10.1128/jcm.34.10.2382-2385.1996] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
169 Medhi S, Goswami B, Das AK, Singh TB, Husain SA, Sehgal A, Kar P. New insights into hepatitis C virus infection in the tribal-dominant part of Northeast India. Arch Virol 2012;157:2083-93. [PMID: 22791109 DOI: 10.1007/s00705-012-1374-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
170 Ruggli N, Rice CM. Functional cDNA Clones of The Flaviviridae: Strategies and Applications. Advances in Virus Research Volume 53. Elsevier; 1999. pp. 183-207. [DOI: 10.1016/s0065-3527(08)60348-6] [Cited by in Crossref: 51] [Cited by in F6Publishing: 36] [Article Influence: 2.2] [Reference Citation Analysis]
171 Cheung RC. Epidemiology of hepatitis C virus infection in American veterans. Am J Gastroenterol. 2000;95:740-747. [PMID: 10710068 DOI: 10.1111/j.1572-0241.2000.01854.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 85] [Article Influence: 3.5] [Reference Citation Analysis]
172 Ravaggi A, Rossini A, Mazza C, Puoti M, Marin MG, Cariani E. Hepatitis C virus genotypes in northern Italy: clinical and virological features. J Clin Microbiol 1996;34:2822-5. [DOI: 10.1128/jcm.34.11.2822-2825.1996] [Cited by in Crossref: 18] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
173 Piccoli Lde Z, Mattos AA, Coral GP, Mattos AZ, Santos DE. Analysis of the sustained virological response in patients with chronic hepatitis C and liver steatosis. Arq Gastroenterol 2011;48:179-85. [PMID: 21952702 DOI: 10.1590/s0004-28032011000300005] [Reference Citation Analysis]
174 Kesson A. Diagnosis and management of paediatric hepatitis C virus infection. Journal of Paediatrics and Child Health 2002;38:213-8. [DOI: 10.1046/j.1440-1754.2002.00804.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
175 Cooreman MP, Schoondermark-Van de Ven EM. Hepatitis C virus: biological and clinical consequences of genetic heterogeneity. Scand J Gastroenterol Suppl 1996;218:106-15. [PMID: 8865460 DOI: 10.3109/00365529609094740] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
176 Hunziker IP, Zurbriggen R, Glueck R, Engler OB, Reichen J, Dai WJ, Pichler WJ, Cerny A. Perspectives: towards a peptide-based vaccine against hepatitis C virus. Molecular Immunology 2001;38:475-84. [DOI: 10.1016/s0161-5890(01)00083-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
177 Abreha T, Woldeamanuel Y, Pietsch C, Maier M, Asrat D, Abebe A, Hailegiorgis B, Aseffa A, Liebert UG. Genotypes and viral load of hepatitis C virus among persons attending a voluntary counseling and testing center in Ethiopia. J Med Virol 2011;83:776-82. [DOI: 10.1002/jmv.21788] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
178 Afridi SQ, Khan N, Akmal M, Ali S, S. A, Bahadar S, Aziz A, Ali N, Hussain F, Awan F, Muddassir Ali M. Distribution of HCV Genotypes and RNA Viral Load Along with Hemato-Biochemical Analysis of HCV Patients in Rahim Yar Khan, Okara and Toba Tek Singh Districts of Punjab, Pakistan. Hepat Mon 2017;17. [DOI: 10.5812/hepatmon.58442] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
179 Zampino R, Pickering J, Iqbal M, Gaud U, Thomas HC, Karayiannis P. Hepatitis G virus/GBV‐C persistence: absence of hypervariable E2 region and genetic analysis of viral quasispecies in serum and lymphocytes. Journal of Viral Hepatitis 2002;6:209-18. [DOI: 10.1046/j.1365-2893.1999.00162.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
180 Theodore D, Fried MW. Natural History and Disease Manifestations of Hepatitis C Infection. In: Hagedorn CH, Rice CM, editors. The Hepatitis C Viruses. Berlin: Springer Berlin Heidelberg; 2000. pp. 43-54. [DOI: 10.1007/978-3-642-59605-6_3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 0.4] [Reference Citation Analysis]
181 Nomura H, Kimura Y, Tada H, Hisano C, Morita C, Okamoto O, Shiraishi G, Kashiwagi S. Predictive Factors of a Response to Interferon Therapy in Chronic Hepatitis C: . Journal of Clinical Gastroenterology 1996;23:185-90. [DOI: 10.1097/00004836-199610000-00006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
182 Katsoulidou AS, Moschidis ZM, Gialeraki RE, Paraskevis DN, Sypsa VA, Lazanas MC, Tassopoulos NC, Psichogiou MA, Boletis JN, Karafoulidou AS, Hatzakis AE. Clinical evaluation of an HIV-1 and HCV assay and demonstration of significant reduction of the HCV detection window before seroconversion: PROCLEIX HIV-1 AND HCV ASSAY EVALUATION. Transfusion 2004;44:59-66. [DOI: 10.1111/j.0041-1132.2003.00591.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
183 Fabrizi F, Lunghi G, Poordad FF, Martin P. Genetic variability of hepatitis C virus in dialysis: the implications. Int J Artif Organs 2002;25:1034-48. [PMID: 12487391 DOI: 10.1177/039139880202501102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
184 Yu ML, Chuang WL, Chen SC, Dai CY, Hou C, Wang JH, Lu SN, Huang JF, Lin ZY, Hsieh MY, Tsai JF, Wang LY, Chang WY. Changing prevalence of hepatitis C virus genotypes: molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan. J Med Virol 2001;65:58-65. [PMID: 11505444 [PMID: 11505444 DOI: 10.1002/jmv.2001] [Cited by in Crossref: 68] [Cited by in F6Publishing: 50] [Article Influence: 3.2] [Reference Citation Analysis]
185 Houghton M. The long and winding road leading to the identification of the hepatitis C virus. J Hepatol. 2009;51:939-948. [PMID: 19781804 DOI: 10.1016/j.jhep.2009.08.004] [Cited by in Crossref: 79] [Cited by in F6Publishing: 53] [Article Influence: 6.1] [Reference Citation Analysis]
186 Maksyutov RA, Gavrilova EV, Maksyutov AZ, Kanev AN. Genotyping of hepatitis B and C virus Russian isolates for reference serum panel construction. J Med Virol. 2015;87:1192-1198. [PMID: 25758235 DOI: 10.1002/jmv.24170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
187 Okamoto H, Kato N, Iizuka H, Tsuda F, Miyakawa Y, Mayumi M. Distinct genotypes of a nonenveloped DNA virus associated with posttransfusion non-A to G hepatitis (TT virus) in plasma and peripheral blood mononuclear cells. J Med Virol 1999;57:252-8. [PMID: 10022796 DOI: 10.1002/(sici)1096-9071(199903)57:3<252::aid-jmv7>3.0.co;2-q] [Cited by in Crossref: 47] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
188 Chandra M, Thippavuzzula R, Ramachandra Rao V, Habib AM, Habibullah CM, Narasu L, Prameela Y, Khaja MN. Genotyping of Hepatitis C virus (HCV) in infected patients from South India. Infection, Genetics and Evolution 2007;7:724-30. [DOI: 10.1016/j.meegid.2007.03.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
189 Iro M, Witteveldt J, Angus AG, Woerz I, Kaul A, Bartenschlager R, Patel AH. A reporter cell line for rapid and sensitive evaluation of hepatitis C virus infectivity and replication. Antiviral Res 2009;83:148-55. [PMID: 19397930 DOI: 10.1016/j.antiviral.2009.04.007] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 3.4] [Reference Citation Analysis]
190 Hadlock KG, Foung SK. GBV-C/HGV: a new virus within the Flaviviridae and its clinical implications. Transfus Med Rev. 1998;12:94-108. [PMID: 9566077 DOI: 10.1016/s0887-7963(98)80032-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
191 Flint M, Quinn ER, Levy S. In search of hepatitis C virus receptor(s). Clin Liver Dis. 2001;5:873-893. [PMID: 11685799 DOI: 10.1016/s1089-3261(05)70199-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
192 Kenny-walsh E. THE NATURAL HISTORY OF HEPATITIS C VIRUS INFECTION. Clinics in Liver Disease 2001;5:969-77. [DOI: 10.1016/s1089-3261(05)70204-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
193 Elzouki A, Verbaan H, Lindgren S, Widell A, Carlson J, Eriksson S. Serine protease inhibitors in patients with chronic viral hepatitis. Journal of Hepatology 1997;27:42-8. [DOI: 10.1016/s0168-8278(97)80278-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
194 Caligaris-cappio F, De Leo AM, Bertero MT. Autoimmune Phenomena and Hepatitis C Virus in Lymphoproliferative and Connective Tissue Disorders. Leukemia & Lymphoma 2009;28:57-63. [DOI: 10.3109/10428199709058331] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
195 Pawlotsky JM. Diagnostic tests for hepatitis C. J Hepatol. 1999;31 Suppl 1:71-79. [PMID: 10622564 DOI: 10.1016/s0168-8278(99)80378-x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
196 Sim H, Wojcik J, Margulies M, Wade JA, Heathcote J. Response to interferon therapy: influence of human leucocyte antigen alleles in patients with chronic hepatitis C. J Viral Hepat. 1998;5:249-253. [PMID: 9751011 DOI: 10.1046/j.1365-2893.1998.00111.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.0] [Reference Citation Analysis]
197 Mondelli MU. Is there a role for immune responses in the pathogenesis of hepatitis C? J Hepatol 1996;25:232-8. [PMID: 8878788 DOI: 10.1016/s0168-8278(96)80080-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
198 Moriguchi H, Uemura T, Kobayashi M, Chung RT, Sato C. Management strategies using pharmacogenomics in patients with severe HCV-1b infection: a decision analysis. Hepatology 2002;36:177-85. [PMID: 12085363 DOI: 10.1053/jhep.2002.33895] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
199 Ravaggi A, Biasin MR, Infantolino D, Cariani E. Comparison of competitive and non-competitive reverse transcription-polymerase chain reaction (RT-PCR) for the quantification of hepatitis C virus (HCV) RNA. Journal of Virological Methods 1997;65:123-9. [DOI: 10.1016/s0166-0934(97)02175-7] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
200 Patel H, Heathcote EJ. When to treat and the benefits of treating hepatitis C in patients with haemophilia. Haemophilia 2009;15:20-32. [DOI: 10.1111/j.1365-2516.2008.01917.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
201 Yun H, Kim D, Kim S, Kang S, Jeong S, Cheon Y, Joe K, Gwon D, Cho S, Jee Y. High prevalence of HBV and HCV infection among intravenous drug users in Korea. J Med Virol 2008;80:1570-5. [DOI: 10.1002/jmv.21255] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
202 Chamberlain RW, Adams NJ, Taylor LA, Simmonds P, Elliott RM. The complete coding sequence of hepatitis C virus genotype 5a, the predominant genotype in South Africa. Biochem Biophys Res Commun. 1997;236:44-49. [PMID: 9223423 DOI: 10.1006/bbrc.1997.6902] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 2.7] [Reference Citation Analysis]
203 Okamoto H, Kobata S, Tokita H, Inoue T, Woodfield GD, Holland PV, Al-Knawy BA, Uzunalimoglu O, Miyakawa Y, Mayumi M. A second-generation method of genotyping hepatitis C virus by the polymerase chain reaction with sense and antisense primers deduced from the core gene. J Virol Methods 1996;57:31-45. [PMID: 8919822 DOI: 10.1016/0166-0934(95)01960-x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
204 Caussin-Schwemling C, Schmitt C, Stoll-Keller F. Study of the infection of human blood derived monocyte/macrophages with hepatitis C virus in vitro. J Med Virol. 2001;65:14-22. [PMID: 11505438 DOI: 10.1002/jmv.1095] [Cited by in Crossref: 68] [Cited by in F6Publishing: 65] [Article Influence: 3.2] [Reference Citation Analysis]
205 Costi C, da Silva CM, Da Fré NN, Grandi T, Hamester FI, Zaha A, Niel C, Rossetti ML. Colorimetric microwell plate reverse-hybridization assay for detection and genotyping of hepatitis C virus. J Virol Methods 2009;162:75-80. [PMID: 19643142 DOI: 10.1016/j.jviromet.2009.07.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
206 Meijer K, Smid WM, Van Der Meer J. Treatment of chronic hepatitis C in haemophilia patients: TREATMENT OF CHRONIC HEPATITIS C IN HAEMOPHILIA PATIENTS. Haemophilia 2000;6:605-13. [DOI: 10.1046/j.1365-2516.2000.00398.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
207 Navas S, Martín J, Quiroga JA, Castillo I, Carreño V. Genetic Diversity and Tissue Compartmentalization of the Hepatitis C Virus Genome in Blood Mononuclear Cells, Liver, and Serum from Chronic Hepatitis C Patients. J Virol 1998;72:1640-6. [DOI: 10.1128/jvi.72.2.1640-1646.1998] [Cited by in Crossref: 102] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
208 Zeuzem S, Franke A, Lee JH, Herrmann G, Ruster B, Roth WK. Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology. Hepatology 1996;24:1003-9. [PMID: 8903367 DOI: 10.1002/hep.510240505] [Cited by in Crossref: 84] [Cited by in F6Publishing: 80] [Article Influence: 3.2] [Reference Citation Analysis]
209 Wei HY, Lu CS, Lin TH. Exploring the P2 and P3 ligand binding features for hepatitis C virus NS3 protease using some 3D QSAR techniques. J Mol Graph Model. 2008;26:1131-1144. [PMID: 18024210 DOI: 10.1016/j.jmgm.2007.10.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
210 Farci P, Bukh J, Purcell RH. The quasispecies of hepatitis C virus and the host immune response. Springer Semin Immunopathol 1997;19:5-26. [DOI: 10.1007/bf00945022] [Cited by in Crossref: 57] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
211 Sacco R, Randone A, Flichman D, Oliveri F, Colombatto P, Scaraggi FA, Bonino F, Schiraldi O, Brunetto MR. The prevalence of hepatitis C virus types in patients of the same geographic area, according to the source of infection and liver disease. Clinical and Diagnostic Virology 1997;8:189-94. [DOI: 10.1016/s0928-0197(97)00019-6] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
212 Rodrı́guez-rosado R, Pérez-olmeda M, Garcı́a-samaniego J, Soriano V. Management of hepatitis C in HIV-infected persons. Antiviral Research 2001;52:189-98. [DOI: 10.1016/s0166-3542(01)00184-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
213 Thiers V, Jaffredo F, Tuveri R, Chodan N, Bréchot C. Development of a simple restriction fragment length polymorphism (RFLP) based assay for HCV genotyping and comparative analysis with genotyping and serotyping tests. J Virol Methods 1997;65:9-17. [PMID: 9128857 DOI: 10.1016/s0166-0934(96)02162-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
214 Sarrazin C, Bruckner M, Herrmann E, Rüster B, Bruch K, Roth WK, Zeuzem S. Quasispecies heterogeneity of the carboxy-terminal part of the E2 gene including the PePHD and sensitivity of hepatitis C virus 1b isolates to antiviral therapy. Virology. 2001;289:150-163. [PMID: 11601926 DOI: 10.1006/viro.2001.1092] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 1.4] [Reference Citation Analysis]
215 Forčić D, Zgorelec R, Šantak M, Košutić T, Mažuran R. Detection of hepatitis C virus RNA in alpha interferon derived from in vitro culture of leukocytes of human origin. Biologicals 2001;29:45-53. [DOI: 10.1006/biol.2001.0275] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
216 Abe K, Edamoto Y, Park YN, Nomura AM, Taltavull TC, Tani M, Thung SN. In situ detection of hepatitis B, C, and G virus nucleic acids in human hepatocellular carcinoma tissues from different geographic regions. Hepatology. 1998;28:568-572. [PMID: 9696026 DOI: 10.1002/hep.510280239] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.2] [Reference Citation Analysis]
217 Pérez V. Viral hepatitis: historical perspectives from the 20th to the 21st century. Arch Med Res. 2007;38:593-605. [PMID: 17613350 DOI: 10.1016/j.arcmed.2006.09.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
218 Sánchez-Quijano A, Abad MA, Torronteras R, Rey C, Pineda JA, Leal M, Macias J, Lissen E. Unexpected high prevalence of hepatitis C virus genotype 4 in Southern Spain. J Hepatol. 1997;27:25-29. [PMID: 9252069 DOI: 10.1016/s0168-8278(97)80275-9] [Cited by in Crossref: 51] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
219 Huang MJ, Tsai SL, Huang BY, Sheen IS, Yeh CT, Liaw YF. Prevalence and significance of thyroid autoantibodies in patients with chronic hepatitis C virus infection: a prospective controlled study. Clin Endocrinol (Oxf). 1999;50:503-509. [PMID: 10468911 DOI: 10.1046/j.1365-2265.1999.00686.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 56] [Article Influence: 2.9] [Reference Citation Analysis]
220 Murakami J, Shimizu Y, Kashii Y, Kato T, Minemura M, Okada K, Nambu S, Takahara T, Higuchi K, Maeda Y, Kumada T, Watanabe A. Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C. Hepatology 1999;30:143-50. [PMID: 10385650 DOI: 10.1002/hep.510300107] [Cited by in Crossref: 90] [Cited by in F6Publishing: 82] [Article Influence: 3.9] [Reference Citation Analysis]
221 Pozzato G, Mazzaro C, Santini G, Burrone O. Hepatitis C virus and non-Hodgkin's lymphomas. Leuk Lymphoma 1996;22:53-60. [PMID: 8724528 DOI: 10.3109/10428199609051728] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
222 Basaras M, Lombera N, de las Heras B, López C, Arrese E, Cisterna R. Distribution of HCV genotypes in patients infected by different sources. Research in Virology 1997;148:367-73. [DOI: 10.1016/s0923-2516(97)89133-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
223 Cerino A, Cividini A, Asti M, Lanza A, Silini E, Mondelli MU. Comparative evaluation of two serologic typing methods for hepatitis C virus. J Clin Microbiol 1996;34:714-6. [DOI: 10.1128/jcm.34.3.714-716.1996] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
224 Leon R, de Medina M, Schiff ER. Diagnostic tools in the evaluation of patients with viral hepatitis undergoing liver transplantation. Liver Transpl Surg. 1998;4:94-103. [PMID: 9457974 DOI: 10.1002/lt.500040114] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
225 Romero M, P??rez-olmeda M, Garc??a-samaniego J, Soriano V. Management of Chronic Hepatitis C in Patients Co-Infected with HIV: Focus on Safety Considerations. Drug Safety 2004;27:7-24. [DOI: 10.2165/00002018-200427010-00002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
226 Kurbanov F, Tanaka Y, Sugauchi F, Kato H, Ruzibakiev R, Zalyalieva M, Yunusova Z, Mizokami M. Hepatitis C virus molecular epidemiology in Uzbekistan. J Med Virol 2003;69:367-75. [DOI: 10.1002/jmv.10298] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
227 Stribling R, Sussman N, Vierling JM. Treatment of hepatitis C infection. Gastroenterol Clin North Am. 2006;35:463-486. [PMID: 16880075 DOI: 10.1016/j.gtc.2006.05.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
228 Fabrizi F, Martin P, Quan S, Dixit V, Brezina M, Conrad A, Polito A, Gitnick G. Serotyping strip immunoblot assay for assessing hepatitis C virus strains in dialysis patients. American Journal of Kidney Diseases 2000;35:832-8. [DOI: 10.1016/s0272-6386(00)70252-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
229 Kumar K, Das M, Rajasekharan Pillai V. Syntheses of four peptides from the immunodominant region of hepatitis C viral pathogens using PS-TTEGDA support for the investigation of HCV infection in human blood: PS-TTEGDA support for SPPS. The Journal of Peptide Research 2000;56:88-96. [DOI: 10.1034/j.1399-3011.2000.00731.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
230 Lin E, Hwang Y, Chen EY. Gene-gene and gene-environment interactions in interferon therapy for chronic hepatitis C. Pharmacogenomics 2007;8:1327-35. [PMID: 17979507 DOI: 10.2217/14622416.8.10.1327] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
231 Iwona BO, Karol P, Kamila CC, Pollak A, Hanna B, Agnieszka P, Andrzej H, Kosińska J, Płoski R, Tomasz L, Marek R. Next-generation sequencing analysis of new genotypes appearing during antiviral treatment of chronic hepatitis C reveals that these are selected from pre-existing minor strains. J Gen Virol 2018;99:1633-42. [PMID: 30394872 DOI: 10.1099/jgv.0.001160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
232 Germer JJ, Zein NN. Advances in the molecular diagnosis of hepatitis C and their clinical implications. Mayo Clin Proc 2001;76:911-20. [PMID: 11560302 DOI: 10.4065/76.9.911] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.1] [Reference Citation Analysis]
233 Mizokami M, Gojobori T, Ohba K, Ikeo K, Ge X, Ohno T, Orito E, Lau JY. Hepatitis C virus types 7, 8 and 9 should be classified as type 6 subtypes. Journal of Hepatology 1996;24:622-4. [DOI: 10.1016/s0168-8278(96)80149-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
234 D’Heygere F, George C, Van Vlierberghe H, Decaestecker J, Nakad A, Adler M, Delwaide J, Laureys A, Nevens F. Efficacy of interferon-based antiviral therapy in patients with chronic hepatitis C infected with genotype 5: a meta-analysis of two large prospective clinical trials. J Med Virol. 2011;83:815-819. [PMID: 21412790 DOI: 10.1002/jmv.22049] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
235 Martín J, Navas S, Fernández M, Rico M, Pardo M, Quiroga JA, Zahm F, Carreño V. In vitro effect of amantadine and interferon alpha-2a on hepatitis C virus markers in cultured peripheral blood mononuclear cells from hepatitis C virus-infected patients. Antiviral Res 1999;42:59-70. [PMID: 10333143 DOI: 10.1016/s0166-3542(99)00017-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
236 Kishine H, Sugiyama K, Hijikata M, Kato N, Takahashi H, Noshi T, Nio Y, Hosaka M, Miyanari Y, Shimotohno K. Subgenomic replicon derived from a cell line infected with the hepatitis C virus. Biochemical and Biophysical Research Communications 2002;293:993-9. [DOI: 10.1016/s0006-291x(02)00342-x] [Cited by in Crossref: 77] [Cited by in F6Publishing: 18] [Article Influence: 3.9] [Reference Citation Analysis]
237 Fujita N, Kaito M, Ishida S, Nakagawa N, Ikoma J, Adachi Y, Watanabe S. Paraformaldehyde protects of hepatitis C virus particles during ultracentrifugation. J Med Virol 2001;63:108-16. [DOI: 10.1002/1096-9071(20000201)63:2<108::aid-jmv1004>3.0.co;2-6] [Cited by in Crossref: 12] [Article Influence: 0.6] [Reference Citation Analysis]
238 Freeman AJ, Marinos G, Ffrench RA, Lloyd AR. Immunopathogenesis of hepatitis C virus infection. Immunol Cell Biol. 2001;79:515-536. [PMID: 11903612 DOI: 10.1046/j.1440-1711.2001.01036.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 61] [Article Influence: 3.1] [Reference Citation Analysis]
239 Simin M, Brok J, Stimac D, Gluud C, Gluud LL. Cochrane systematic review: pegylated interferon plus ribavirin vs. interferon plus ribavirin for chronic hepatitis C: SYSTEMATIC REVIEW: INTERFERON FOR HEPATITIS C. Alimentary Pharmacology & Therapeutics 2007;25:1153-62. [DOI: 10.1111/j.1365-2036.2007.03294.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 3.3] [Reference Citation Analysis]
240 Ni Y, Chang M, Lin K, Chen P, Lin D, Hsu H, Chen D. Hepatitis C Viral Infection in Thalassemic Children: Clinical and Molecular Studies. Pediatr Res 1996;39:323-8. [DOI: 10.1203/00006450-199602000-00022] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
241 Pawlotsky JM. Hepatitis C virus genetic variability: pathogenic and clinical implications. Clin Liver Dis. 2003;7:45-66. [PMID: 12691458 DOI: 10.1016/s1089-3261(02)00065-x] [Cited by in Crossref: 147] [Cited by in F6Publishing: 45] [Article Influence: 7.7] [Reference Citation Analysis]
242 Caccamo L, Gridelli B, Sampietro M, Melada E, Doglia M, Lunghi G, Corbetta N, Rossi G, Colledan M, Fassati LR, Fiorelli G, Galmarini D. Hepatitis C virus genotypes and reinfection of the graft during long-term follow-up in 35 liver transplant recipients. Transpl Int 1996;9 Suppl 1:S204-9. [PMID: 8959828 DOI: 10.1007/978-3-662-00818-8_52] [Reference Citation Analysis]
243 González-Carmona MA, Quasdorff M, Vogt A, Tamke A, Yildiz Y, Hoffmann P, Lehmann T, Bartenschlager R, Engels JW, Kullak-Ublick GA, Sauerbruch T, Caselmann WH. Inhibition of hepatitis C virus RNA translation by antisense bile acid conjugated phosphorothioate modified oligodeoxynucleotides (ODN). Antiviral Res 2013;97:49-59. [PMID: 23142319 DOI: 10.1016/j.antiviral.2012.10.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
244 Ehrnsperger M, Hergersberg C, Wienhues U, Nichtl A, Buchner J. Stabilization of Proteins and Peptides in Diagnostic Immunological Assays by the Molecular Chaperone Hsp25. Analytical Biochemistry 1998;259:218-25. [DOI: 10.1006/abio.1998.2630] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 1.5] [Reference Citation Analysis]
245 Itoh K, Hirakawa K, Okamoto H, Ukita M, Tanaka H, Sawada N, Tsuda F, Miyakawa Y, Mayumi M. Infection by an unenveloped DNA virus associated with non-A to -G hepatitis in Japanese blood donors with or without elevated ALT levels. Transfusion 1999;39:522-6. [PMID: 10336003 DOI: 10.1046/j.1537-2995.1999.39050522.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 0.8] [Reference Citation Analysis]
246 Dentico P, Sacco R, Volpe A, Ranieri C, Carabellese S, Carbone M, Casalino C, Buongiorno R. Hepatitis C virus serotypes in haemodialysis patients in South-East Italy. Scand J Infect Dis 2000;32:143-6. [PMID: 10826898 DOI: 10.1080/003655400750045231] [Reference Citation Analysis]
247 Morales J. Renal transplantation in patients positive for hepatitis B or C (Pro). Transplantation Proceedings 1998;30:2064-9. [DOI: 10.1016/s0041-1345(98)00542-9] [Cited by in Crossref: 18] [Article Influence: 0.8] [Reference Citation Analysis]